Fig. 3
From: Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12874-020-01017-8/MediaObjects/12874_2020_1017_Fig3_HTML.png)
Minimax, admissible and optimal design for (p0, p1, α, β) = (0.05, 0.25, 0.05, 0.10) based on Simon’s design
From: Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
Minimax, admissible and optimal design for (p0, p1, α, β) = (0.05, 0.25, 0.05, 0.10) based on Simon’s design